Clinical Studies

Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
Obesity/Weight Management
Women's Health
Other

Special Features
Advances/Research

Multi-Center Clinical Study to Determine the Effectiveness and Safety of HEDA™ in the Screening of Women for Breast Cancer

Time frame of study:		Ongoing
Location of Study:		Beth Israel Medical Center
Contact:		Continuum Cancer Center Research Program (212) 844-6286

Summary:
The purpose of the HEDA breast scan study is to evaluate a new screening technique against the current standard, mammography. If this technology is effective, it may lead to a portable test that is less expensive, more comfortable and does not include radiation. The Azura BreastScan™ device used in this study, scans for tumors by measuring low voltage electrical currents through the breast from the skin surface and then analyzes the electrical fields created by these currents by comparing one breast to the other. Preliminary studies have shown that the technique used by this device (called impedance scanning) can successfully detect very small tumors.

Eligibility:
Eligible subjects include women ages 30-50 who are scheduled for bilateral screening mammography or biopsy, and meet the inclusion/exclusion criteria for the protocol including no prior history of breast biopsies, surgeries or active skin conditions. Please call for more information.

Benefits and/or Compensation:
There is no monetary compensation for participation in this study. If successful, this study will result in a new technique for the early detection of breast cancer potentially extending the availability of preventive screening.